作者: Kevin P. Banks , Won S. Song
DOI: 10.1016/J.RCL.2013.05.003
关键词: Positron Emission Tomography-Computed Tomography 、 Image fusion 、 Neoadjuvant therapy 、 18 f fluorodeoxyglucose 、 Medicine 、 Radiology 、 Fluorodeoxyglucose 、 Positron emission tomography 、 Computed tomography 、 Radiology Nuclear Medicine and imaging 、 General Medicine
摘要: Positron emission tomography (PET) has proved itself to be valuable in the evaluation of patients with a wide array gastrointestinal (GI) malignancies. Subsequent development fusion imaging PET and computed (PET-CT) scanners significantly advanced capabilities by combining functional data the(18)F-labeled glucose analogue fluorodeoxyglucose (FDG) conventional anatomic provided CT. This article reviews evolving role FDG PET-CT initial assessment monitoring GI tumors. Specific applications are discussed, normal variants benign findings frequently encountered during tract reviewed.